InvestorsHub Logo
Followers 3156
Posts 961092
Boards Moderated 205
Alias Born 09/04/2000

Re: BooDog post# 1534

Tuesday, 05/04/2021 5:33:39 PM

Tuesday, May 04, 2021 5:33:39 PM

Post# of 2847
ibox is sharp & to da point / Sonnet BioTherapeutics Inc (SONN)'

About Sonnet BioTherapeutics Holdings, Inc.

Founded in 2011, Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating
biologic drugs of single or bispecific action.

Known as FHAB (Fully Human Albumin Binding),
the technology utilizes a fully human single chain antibody fragment
(scFv)
that binds to and "hitch-hikes" on human serum albumin (HSA) for transport to target tissues.

Sonnet's FHAB was designed to specifically target tumor and lymphatic tissue,
with an improved therapeutic window for optimizing the safety
and efficacy of immune modulating biologic drugs.

FHAB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes,
including cytokines, peptides, antibodies and vaccines.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SONN News